Human Genome

DNA is usually considered to have a double helix. But now researchers from the Garvan Institute of Medical Research found out over 50,000 peculiar DNA structures that resemble 'knots' in the human genome-shaped structures called i-motifs. Their findings were published in The EMBO Journal. A landmark 2018 study, Garvan scientists were the first in the world to directly observe i-motifs inside living human cells using a new antibody tool they had developed, that was able specifically to bind to them. The new work builds on that by using that antibody to map the locations of i-motifs across the whole genome. In this study, we mapped more than 50,000 i-motif sites in the human genome that occur in all three of the cell types we examined, That’s a remarkably high number for a DNA structure whose existence in cells was once considered controversial. Our findings confirm that i-motifs are not just laboratory curiosities but widespread – and likely to play key roles in genomic function. Professor Daniel Christ I-motifs are a structure of DNA, somehow different from the usual double helix. I-Motifs arise because of the persistence of cytosine nucleotide chains within one strand of the DNA which interact with each other to form a four-stranded helical structure extruded from the double helix. It was discovered by the researchers that i-motifs are not dispersed randomly but rather are clustered in important functional sections of the genome, such as those that regulate gene activity. We discovered that i-motifs are associated with genes that are highly active during specific times in the cell cycle. This suggests they play a dynamic role in regulating gene activity, We also found that i-motifs form in the promoter region of oncogenes, for instance the MYC oncogene, which encodes one of cancer’s most notorious ‘undruggable’ targets. This presents an exciting opportunity to target disease-linked genes through the i-motif structure Cristian David Peña Martinez The widespread presence of i-motifs near these ‘holy grail’ sequences involved in hard-to-treat cancers opens up new possibilities for new diagnostic and therapeutic approaches. It might be possible to design drugs that target i-motifs to influence gene expression, which could expand current treatment options. Sarah Kummerfeld Also, Read| Memories are passed down to offspring by bacterial cells This study is an example of how fundamental research and technological innovation can come together to make paradigm-shifting discoveries. Cristian David Peña Martinez Source: Garvan Institute of Medical Research Journal Reference: Peña Martinez, Cristian David et al. “Human genomic DNA is widely interspersed with i-motif structures.” The EMBO journal, 10.1038/s44318-024-00210-5. 29 Aug. 2024, DOI: 10.1038/s44318-024-00210-5. Last Modified:

Tag: Human Genome

Researchers map fifty thousand of the human genome’s cryptic “knots” of DNA

Areas Covered

Discover More

Pfizer and Valneva Announce Strong Efficacy for Lyme Disease Vaccine Candidate

Novo Nordisk’s UBT251 Triple Agonist Achieves Landmark 2.16% HbA1c Reduction in Type 2 Diabetes Phase 2 Trial

Novartis Immunology Data at AAD 2026: Rhapsido and Cosentyx Results

GSK Secures Japan Orphan Drug Designation for Risvutatug Rezetecan in Small-Cell Lung Cancer

Pfizer’s Talzenna + Xtandi Delivers Proven rPFS Breakthrough in HRR-Mutated mCSPC

Eli Lilly Declares Powerful 2% A1C Reduction and 17% Weight Loss in Landmark Phase 3 Trial Results of Retatrutide